Phase I clinical study of personalized peptide vaccination combined with radiotherapy for advanced hepatocellular carcinoma

AIM: To assess the efficacy and safety of a new treatment modality, cellular immune therapy based on personalized peptide vaccination (PPV-DC-CTL) combined with radiotherapy, for treating advanced hepatocellular carcinoma (HCC). METHODS: A total of nine patients with advanced HCC were enrolled. Mult...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Jie, Wang, Li-Feng, Zou, Zheng-Yun, Kong, Wei-Wei, Yan, Jing, Meng, Fan-Yan, Chen, Fang-Jun, Du, Juan, Shao, Jie, Xu, Qiu-Ping, Ren, Hao-Zhen, Li, Ru-Tian, Wei, Jia, Qian, Xiao-Ping, Liu, Bao-Rui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2017
Materias:
Clinical Trials Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5550789/
https://www.ncbi.nlm.nih.gov/pubmed/28839440
http://dx.doi.org/10.3748/wjg.v23.i29.5395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5550789/
https://www.ncbi.nlm.nih.gov/pubmed/28839440
http://dx.doi.org/10.3748/wjg.v23.i29.5395

Ejemplares similares